L-carnitine may support fat-burning capacity during exercise and energy-restricted states, but clinical evidence in semaglutide users is limited
Tirzepatide is a dual glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptor agonist that is the active ingredient in other FDA-approved drugs for the treatment of type 2 diabetes mellitus
We can gradually reduce your medication dosage over time, allowing you to feel comfortable without it while successfully maintaining your weight through your efforts
However, because severe liver dysfunction (such as markedly elevated liver enzymes or decompensated cirrhosis) has not been specifically studied, caution is advised in that population
This magic blend, customized to each individual, creates a base for genuine, sustainable transformation
A lower or slower escalation can change early results, but it may also change side-effect burden